MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Natera Inc

Slēgts

SektorsVeselības aprūpe

138.8 -3.14

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

138.44

Max

143.48

Galvenie mērījumi

By Trading Economics

Ienākumi

-13M

-67M

Pārdošana

26M

502M

Peļņas marža

-13.338

Darbinieki

4,424

EBITDA

-33M

-79M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+44.45% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 7. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

301M

22B

Iepriekšējā atvēršanas cena

141.94

Iepriekšējā slēgšanas cena

138.8

Ziņu noskaņojums

By Acuity

30%

70%

80 / 376 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

Natera Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 18. jūl. 21:01 UTC

Peļņas

Charles Schwab Profit Jumps on Tariff Trading Surge -- 2nd Update

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 18. jūl. 20:50 UTC

Tirgus saruna
Peļņas

Basic Materials Roundup: Market Talk

2025. g. 18. jūl. 20:46 UTC

Peļņas

Strong Earnings Fuel Stock-Market Records This Week -- WSJ

2025. g. 18. jūl. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific Considering a Norfolk Southern Buyout, Report Says. Here's What Will Matter. -- Barrons.com

2025. g. 18. jūl. 20:36 UTC

Peļņas

3M Gives Investors a 'Beat and Raise.' The Stock Is Rising. -- Barrons.com

2025. g. 18. jūl. 20:16 UTC

Iegādes, apvienošanās, pārņemšana

Chevron-Hess Deal Close Is Good News for Wall Street's Takeover Arbitragers -- Barrons.com

2025. g. 18. jūl. 20:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 18. jūl. 20:02 UTC

Tirgus saruna

Gold Higher to Close Out Week -- Market Talk

2025. g. 18. jūl. 19:14 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

2025. g. 18. jūl. 19:06 UTC

Tirgus saruna

Oil Futures Snap Two-Week Winning Streak -- Market Talk

2025. g. 18. jūl. 18:24 UTC

Peļņas

These Stocks Are Moving the Most Today: Netflix, Sarepta, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, and More -- Barrons.com

2025. g. 18. jūl. 18:19 UTC

Peļņas

American Express Shares Drop as Earnings Beat, Record Revenue Fail to Impress -- Barrons.com

2025. g. 18. jūl. 18:11 UTC

Iegādes, apvienošanās, pārņemšana

Oil CEOs Get Their Revenge on Biden's Antitrust Enforcers -- WSJ

2025. g. 18. jūl. 18:11 UTC

Peļņas

Netflix Earnings Show That YouTube Is the Streamer to Fear -- Barrons.com

2025. g. 18. jūl. 17:35 UTC

Tirgus saruna

U.S. Oil Rig Count Falls by 2 to 422 -- Market Talk

2025. g. 18. jūl. 16:29 UTC

Tirgus saruna

Crude Rally on EU's Russia Sanctions Peters Out -- Market Talk

2025. g. 18. jūl. 16:28 UTC

Iegādes, apvienošanās, pārņemšana

Union Pacific Considering a Norfolk Southern Buyout, Report Says. Here's What Will Matter. -- Barrons.com

2025. g. 18. jūl. 16:22 UTC

Peļņas

These Stocks Are Moving the Most Today: Netflix, Amex, Norfolk Southern, Interactive Brokers, Talen, Schwab, Sarepta, and More -- Barrons.com

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Financial Services Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Energy & Utilities Roundup: Market Talk

2025. g. 18. jūl. 16:20 UTC

Tirgus saruna
Peļņas

Basic Materials Roundup: Market Talk

2025. g. 18. jūl. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 18. jūl. 16:04 UTC

Peļņas

Charles Schwab Profit Jumps on Tariff Trading Surge -- Update

2025. g. 18. jūl. 15:58 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 18. jūl. 15:58 UTC

Tirgus saruna

Aluminum Gains on U.S. Dollar Weakness, Scrap Imports -- Market Talk

2025. g. 18. jūl. 15:47 UTC

Tirgus saruna
Peļņas

Netflix Shifting Focus to Engagement with New Content -- Market Talk

Salīdzinājums

Cenas izmaiņa

Natera Inc Prognoze

Cenas mērķis

By TipRanks

44.45% augšup

Prognoze 12 mēnešiem

Vidējais 207.11 USD  44.45%

Augstākais 251 USD

Zemākais 185 USD

Pamatojoties uz 10 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Natera Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

10 ratings

10

Pirkt

0

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

153.79 / N/AAtbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bullish Evidence

Noskaņojums

By Acuity

80 / 376 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Natera Inc

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.